Diabetic Macular Oedema clinical trials

Explore recruiting diabetic macular oedema clinical trials.

Recruiting diabetic macular oedema studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diabetic Macular Oedema trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes (FOCUS)

Portugal, Poland, Spain, Romania, Czechia, Germany +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

EMMA - Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema

France

Therapeutic use (Phase IV) EU CTIS Study details

LOADEX: PILOT AND PHASE 2 STUDY OF THE EFFICACY OF A TREATMENT PROTOCOL WITH DEXAMETHASONE IMPLANT LOADING DOSE IN PATIENTS WITH DIABETIC MACULAR EDEMA

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-masked, Multi-center, 3-Arm Pivotal Phase 2/3 Study to Evaluate the Efficacy and Safety of Intravitreal EYE103 Compared with Intravitreal ranibizumab (0.5mg) in Participants with Diabetic Macular Edema

Italy, Spain, Slovakia, Poland, Portugal, Croatia +6 more

Phase II and Phase III (Integrated) EU CTIS Study details

A randomised, double-masked, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of oral BI 1815368 in participants with centre-involved diabetic macular edema for 48 weeks of treatment (THULITE)

Germany, Slovakia, Poland, Hungary, Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

Diabetic Macular Oedema trials by city

Diabetic Macular Oedema clinical trials

Recruiting diabetic macular oedema studies right now

Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)

EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema

Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)

Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients

Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients

Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy

MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant

Gene Therapy for Diabetic Macular Edema

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME